Código QR (código de barras bidimensional)

Safety signals of zolbetuximab in gastric or gastroesophageal junction adenocarcinoma: a comprehensive analysis of the FDA adverse event reporting system (FAERS) data

BackgroundZolbetuximab is a novel monoclonal antibody targeting CLDN18.2 for advanced gastric or gastroesophageal junction adenocarcinoma. However, its large-scale, real-world safety profile remains incompletely characterized. This study aimed to analyze its post-marketing adverse events using the F...

ver descrição completa

Na minha lista:
Principais autores: Li Lin, Maohua Chen, Chenmin Wu, Hong Chen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-07-01
coleção:Frontiers in Oncology
Assuntos:
adverse event
disproportionality analysis
FAERS database
pharmacovigilance
zolbetuximab
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2026.1787423/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados